Aelan Cell Technologies to Showcase Advances in Next Generation Regenerative Product at 14th Annual Meeting of International Federation for Adipose Therapeutics and Science (IFATS)
Aelan's novel technology is a combination device for the controlled, versatile and measured production of biologics which has been positioned as a new generation of regenerative therapy products for multiple indications.
Aelan Cell Technologies and the Buck Institute Announce Licensing Agreement
The agreement gives Aelan world-wide rights to intellectual property. Aelan Cell Technologies today announced a licensing agreement with the Buck Institute for Research on Aging (Novato). The agreement gives Aelan world-wide rights to intellectual property describing a novel epigenetic biomarker with a granted United States patent.
An early human clinical feasibility study has indicated that serological tests using the biomarker alongside other proprietary components developed by Aelan's researchers could potentially help physicians diagnose Alzheimer's disease (AD).
This funding will support the continued development and commercialization of the Company's injectable drug delivery device platform.
A recent study published in Proceedings of the National Academy of Sciences and conducted by a team of researchers at the Georgia Institute of Technology and Aelan Cell Technologies has identified regulatory elements that allow for the creation of a diverse range of different cell types from different genetic information.
Building on its recent formation of Mount Tam Biotechnologies, US Equity Holdings is actively expanding its interest in biotechnology and will shortly announce its next significant venture.
US Equity Holdings' newly established entity, Mount Tam Biotechnologies, has completed an exclusive worldwide licensing and collaboration agreement with the Buck Institute for Research on Aging.
Chester Aldridge, Chairman and CEO of US Equity Holdings, has joined Fraunhofer's Pompeii Sustainable Preservation Project (PSPP) as a Strategic Advisor.
Aelan Cell Technologies is engaged in the research, discovery, development and commercialization of innovative biomedical technologies for the advancement of human health and longevity.
Mount Tam Biotechnologies is a specialty biopharmaceutical company focused on the discovery and development of novel mTOR modulators to address serious unmet need across a range of therapeutic areas.
PV Tech Group provides a comprehensive range of services to photovoltaic manufacturers, including full-scale integration of photovoltaic manufacturing facilities (wafers, cells, modules), strategic planning, technical evaluation, process optimization and project management.
Credence MedSystems is a drug delivery and specialty pharmaceutical company focused on delivering medications safely for the benefit of our patients, caregivers and partners.
CURE is a preeminent developer and manufacturer of the most advanced oral thin film (CureFilm™) on the market today with an industry leading full service cGMP manufacturing facility.
Prosetta Biosciences, Inc. is biotechnology company focused on developing novel small-molecule antiviral therapeutics based on over 25 years of basic research on the Cell-Free Protein Synthesizing Systems (CFPSS).